A 54-year-old man with slowness of movement and confusion

Neurology

Volumn 69, Issue 19, 2007, Pages 1881-1887

  Geschwind, Michael D ^a   Josephs, Keith A ^b   Parisi, Joseph E ^b   Keegan, B Mark ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BALANCE DISORDER; BODY POSTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DIZZINESS; ELECTROENCEPHALOGRAM; HUMAN; HYPOPHONIA; MALE; MOTOR DYSFUNCTION; MUSCLE TWITCH; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOSENSITIVITY; PRIORITY JOURNAL; SPEECH DISORDER; STARTLE REFLEX;

EID: 35948944965     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000290370.14036.69     Document Type: Article

References (25)

1. Cummings J. Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50:73-80.
2. Josephson SA, Papanastassiou AM, Berger MS, et al. The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia. J Neurosurg 2007;106:72-75.
3. Moritani T, Hiwatashi A, Shrier DA, Wang HZ, Numaguchi Y, Westesson PL. CNS vasculitis and vasculopathy: efficacy and usefulness of diffusion-weighted echoplanar MR imaging. Clin Imaging 2004;28:261-270.
4. Lee SY, Chu K, Park KI, Jeong SW, Yoon BW. Diffusion-weighted MR findings in isolated angiitis of the central nervous system (IACNS). Acta Neurol Scand 2003;108:346-351.
5. Geschwind MD, Jay C. Assessment of rapidly progressive dementias. Concise review related to chapter 362: Alzheimer's disease and other primary dementias in Harrison's Textbook of Internal Medicine [online]. Available at: http://harrisons.accessmedicine.com/. Accessed June 6, 2007.
6. Ruggieri RM, Lupo I, Piccoli F. Pancreatic encephalopathy: a 7-year follow-up case report and review of the literature. Neurol Sci 2002;23:203-205.
7. Boon P, de Reuck J, Achten E, de Bleecker J. Pancreatic encephalopathy. A case report and review of the literature. Clin Neurol Neurosurg 1991;93:137-141.
8. Jungreis AC, Schaumburg HH. Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol). Neurology 1993;43:1265.
9. Le Quesne PM. Metal-induced diseases of the nervous system. Br J Hosp Med 1982;28:534-538.
10. Bataller L, Kleopa KA, Wu GF, Rossi JE, Rosenfeld MR, Dalmau J. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry 2007;78:381-385.
11. Vernino S, Geschwind MD, Boeve B. Autoimmune encephalopathies. The Neurologist 2007;13:140-147.
12. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol 2003;60:164-171.
13. Seipelt M, Zerr I, Nau R, et al. Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1999;66:172-176.
14. Chang CC, Eggers SD, Johnson JK, Haman A, Miller BL, Geschwind MD. Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 2007;109:54-57.
15. Black SE. Focal cortical atrophy syndromes. Brain Cogn 1996;31:188-229.
16. Geschwind MD, Haman A, Torres-Chae C, Raudabaugh BJ, Devereux G, Miller BL. CSF findings in a large United States sporadic CJD cohort. Neurology 2007;68 (suppl 1):A142.
17. Geschwind MD, Martindale J, Miller D, et al. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2003;60:813-816.
18. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005;26:1551-1562.
19. WHO Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: Report of a WHO consultation. In: World Health Organization: Emerging and other communicable diseases, surveillance and control. Geneva: WHO; February 9-11, 1998.
20. Collins SJ, Sanchez-Juan P, Masters CL, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006;129:2278-2287.
21. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004;63:443-449.
22. Tschampa HJ, Kallenberg K, Urbach H, et al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain 2005;128:2026-2033.
23. Brown P, Wolff A, Gajdusek DC. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 1990;40:887-890.
24. Budka H, Head MW, Ironside JW, et al. Sporadic Creutzfeldt-Jakob disease. In: Dickson DW, ed. Neurodegeneration: The molecular pathology of dementia and movement disorders. Basel: ISN Neuropath Press; 2003:287-297.
25. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-233.